<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T16:51:17Z</responseDate>
  <request identifier="oai:figshare.com:article/33721831" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33721831</identifier>
        <datestamp>2026-09-14T08:15:44Z</datestamp>
        <setSpec>portal_1197</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data for Comprehensive vibrational spectroscopic investigation of trans,trans,trans-[Pt(N3)2(OH)2(py)2], a Pt(IV) diazido anticancer prodrug candidate</dc:title>
          <dc:creator>Robbin Vernooij (24870259)</dc:creator>
          <dc:creator>Tanmaya Joshi (1801927)</dc:creator>
          <dc:creator>Evyenia Shaili (2815306)</dc:creator>
          <dc:creator>Manja Kubeil (1782781)</dc:creator>
          <dc:creator>Dominique R. T. Appadoo (20391917)</dc:creator>
          <dc:creator>Ekaterina I. Izgorodina (1538968)</dc:creator>
          <dc:creator>Bim Graham (397733)</dc:creator>
          <dc:creator>P. J. Sadler (24740740)</dc:creator>
          <dc:creator>Bayden R. Wood (695392)</dc:creator>
          <dc:creator>Leone Spiccia (1405969)</dc:creator>
          <dc:subject>Antineoplastic agents</dc:subject>
          <dc:subject>Cancer -- Chemotherapy</dc:subject>
          <dc:subject>Migrated from ePrints</dc:subject>
          <dc:description>We report a detailed study of a promising photoactivatable metal-based anticancer prodrug candidate, trans,trans,trans-[Pt(N3)2(OH)2(py)2] (C1; py = pyridine), using vibrational spectroscopic techniques. Attenuated total reflection Fourier transform infrared (ATR-FTIR), Raman, and synchrotron radiation far-IR (SR-FIR) spectroscopies were applied to obtain highly resolved ligand and Pt-ligand vibrations for C1 and its precursors (trans-[Pt(N3)2(py)2] (C2) and trans-[PtCl2(py)2] (C3)). Distinct IR- and Raman-active vibrational modes were assigned with the aid of density functional theory calculations, and trends in the frequency shifts as a function of changing Pt coordination environment were determined and detailed for the first time. The data provide the ligand and Pt-ligand (azide, hydroxide, pyridine) vibrational signatures for C1 in the mid- and far-IR region, which will provide a basis for the better understanding of the interaction of C1 with biomolecules.&lt;br&gt;&lt;br&gt;Dataset contains following items: DFT_output_files (Gaussian 09 log format) Raw_spectral_data (ATR_FTIR &amp; SR_FIR = OPUS format, Raman = txt format)</dc:description>
          <dc:date>2026-09-14T08:15:44Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.82444/warw.33721831.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_for_Comprehensive_vibrational_spectroscopic_investigation_of_trans_trans_trans-_Pt_N3_2_OH_2_py_2_a_Pt_IV_diazido_anticancer_prodrug_candidate/33721831</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
